DRUG

CLASSIFICATION/ INDICATION

DOSE/RATE/ FREQUENCY

ACTION

CONTRAINDICATION

SIDE EFFECTS

NURSING RESPONSIBILITIES

GENERIC NAME: Salbutamol BRAND NAME: Activent Airomir Asbunyl Asfrenon Asmarex

CLASSIFICATION: Respiratory Drug INDICATION: Relief of brochospasm in bronchial asthma, chronic bronchitis, emphysema and other reversible, obstructive pulmonary diseases. Also useful for treating bronchospasm in patients with coexisting heart disease of hypertension.

1cc + 1 cc !"" # $o for nebuli%ation

"timulates beta-& receptors of bronchioles by increasing levels of cA'( which relaxes smooth muscles to produce bronchodilatati on. Also causes )!" stimulation, cardiac stimulation, increased diuresis, s*eletal muscle tremors and increased gastric acid secretion. +onger acting than isoproterenol.

,ypersensitivity to salbutamol, also to atropine and its derivatives. -hreatened abortion during the 1st and &nd trimester. )ardiac arrhythmia associated with tachycardia caused by digitalis intoxication. ,ypertrophic obstructive cardiomyopathy or tachyarrythmia. -hrotoxicosis. (revention of premature labor associated with toxemia of pregnancy or antepartum hemorrhage. +actation. .se with non-selective betabloc*ers.

MUSCULAR: fine s*eletal muscle tremor, leg cramps CIRCULATORY: palpitations, tachycardia, hypertension CNS: headache, nausea, vomiting, di%%iness, hyperactivity, insomnia RESPIRATORY: bronchospasm, cough, bronchitis, heartburn, epistaxis GI: /0 discomfort, unusual taste, dyspepsia

Assess cardiorespiratory function1 23(, heart rate and rhythm and breath sounds. Determine history of previous medication and ability to self medicate to prevent additive. 'onitor for evidence of allergic reactions and paradoxical bronchospasm. /ive oral administration with meals. 0n elderly patients, a spacing device is advised.

DRUG

CLASSIFICATION/ INDICATION

DOSE/RATE/ FREQUENCY

ACTION

CONTRAINDICATION

SIDE EFFECTS

NURSING RESPONSIBILITIES

GENERIC NAME: Ceftria o!e BRAND NAME: 4orgram 5eptrix 'egion (antrixon Retro*or

CLASSIFICATION: Anti-infective INDICATION: -reatment of susceptible infections including chancroid, gastroenteritis, lyme disease, meningitis, syphilis, typhoid fever, 6hipple7s disease. Delayed stage with neurological and articular systemic manifestations. -reatment of +R-0, s*in and soft tissue infections, .-0, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia, intraabdominal infections, meningitis. (re-

1g 08 9-: A!"# 1& o

0nhibits bacterial cell wall synthesis, rendering cell wall osmotically unstable, leading to cell death.

,ypersensitivity to cephalosporins and penicillins, lidocaine or any other local anaesthetic product of the amide type. !eonates and premature infants with billirubin encephalopathy. (eristalsis-inhibiting preparations. (orphyria, unapplianced auricula-ventricular bloc*; cardiogenic shoc*.

INTEGUMENTARY : exanthema, allergic dermatitis, pruritus, urticaria, edema, erythema multiforme HEMATOLOGY: eosinophilia, leu*openia, granulocytopenia, hemolytic anemia, thrombocytopenia CNS: headache, di%%iness REPRODUCTIVE: vaginitis GI: diarrhea, nausea, vomiting, stomatitis, glossitis

Assess patient7s previous sensitivity reaction to penicillin or other cephalosporins. Assess patient for sign and symptoms of infection before and during treatment1 fever, earache, characteristics of wounds, sputums, urine, stool and 62) <1=,===3mm>. ?btain )@" before beginning drug therapy to identify if correct treatment has been initiated. Assess renal function before and during therapy1 urine output, 2.! and creatinine. 'onitor for nephrotoxicity. Assess for possible

operative prophylaxis to reduce chance of post-operative surgical infections.

superinfection1 perineal itching, fever, malaise, redness, pain, swelling, drainage, rash, diarrhea and change in cough or sputum. "evere diarrhea may indicate pseudomembranou s colitis.

DRUG

CLASSIFICATION/ INDICATION

DOSE/RATE/ FREQUENCY

ACTION

CONTRAINDICATION

SIDE EFFECTS

NURSING RESPONSIBILITIES

GENERIC NAME: Para"etamol BRAND NAME: Aldep Alvedon Aminofebrin 2iogesic /eran

CLASSIFICATION: Analgesic INDICATION: Relief of mild-tomoderate pain; treatment of fever

1& mg (R! # A o for -B>C.$ o)

Decreases fever by inhibiting the effects of pyrogens on the hypothalamic heat regulating centers and by a hypothalamic action leading to sweating and vasodilatation. Relieves pain by inhibiting prostaglandin synthesis at the )!".

,ypersensitivity; intolerance to tartra%ine, alcohol, table sugar, saccharin.

INTEGUMENTARY : rash, urticaria, hypersensitivity, cyanosis HEMATOLOGY: neutropenia, leu*openia, hemolytic anemia, thrombocytopenia CNS: stimulation, drowsiness, nausea, vomiting, RENAL: renal failure, hepatotoxicity, hepatic sei%ure GI: abdominal pain

Assess patient7s fever or pain1 type of pain, location, intensity, duration, temperature, and diaphoresis. Assess allergic reactions1 rash, urticaria Assess hepatotoxicity1 dar* urine, clay-colored stools. Dellowing of s*in and sclera; itching, abdominal pain, fever, diarrhea 'onitor liver functions. A"-, A+-, billirubin, protime, 2.!, )REA. )hec* input and output ratio.